MyAverix Finance
SHG · Healthcare
China National Medicines Corp Ltd (600511)
Medical Distribution
China National Medicines Corp Ltd (600511) is listed on SHG in the Healthcare sector. Industry: Medical Distribution. As of 2026-03-28, reported market cap is $21.83B, P/E ratio is 10.92, net margin is 3.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600511
China National Medicines Corp Ltd (600511) — FAQ
What is China National Medicines Corp Ltd's market cap?
China National Medicines Corp Ltd (600511) has a reported market cap of $21.83B (data as of 2026-03-28).
What is 600511's P/E ratio?
The price-to-earnings (P/E) ratio for China National Medicines Corp Ltd (600511) is 10.92 (data as of 2026-03-28).
Does China National Medicines Corp Ltd pay a dividend?
Dividend yield is not available in the current snapshot for China National Medicines Corp Ltd (600511). Check the MyAverix Finance app for the latest dividend data.
What sector is China National Medicines Corp Ltd in?
China National Medicines Corp Ltd (600511) is classified in the Healthcare sector (Medical Distribution industry).
What exchange is 600511 listed on?
600511 is listed on SHG.
What is China National Medicines Corp Ltd's net margin?
China National Medicines Corp Ltd (600511) reports a net margin of 3.9% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.